Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2023 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2023 Earnings Call Transcript May 10, 2023

Ginkgo Bioworks Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09.

Anna Marie Wagner: Good afternoon. I’m Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. I’m joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. Thanks as always for joining us. We’re looking forward to updating you on our progress. As a reminder,...